Top

Published in:

01-08-2014 | Literatur kommentiert

Eine Strahlentherapie des initialen Bulks verbessert nach abgeschlossener Immunchemotherapie das Outcome älterer Patienten mit aggressivem B-Zell-Lymphom

Author: Prof. Dr. Stefan Kubicka

Published in: Strahlentherapie und Onkologie | Issue 8/2014

Auszug

Held G, Murawski N, Ziepert M et al (2013) Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol 51:4505 …

Held G, Murawski N, Ziepert M et al (2014) Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol. doi:10.1200/JCO.2013.51.4505

Ng AK, Bernardo MV, Weller E et al (2002) Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 100:1989–1996CrossRefPubMed

Galper SL, Yu JB, Mauch PM et al (2011) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117:412–418CrossRefPubMed

Ng AK, Bernardo MP, Weller E et al (2002) Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol 20:2101–2108CrossRefPubMed

Miller TP, Dahlberg S, Cassady JR et al (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. N Engl J Med 339:21–26CrossRefPubMed

Miller T, Leblanc M, Spier C et al (2001) CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin’s lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial. Blood 98:724aCrossRef

Coiffier B, Thieblemont C, Van Den Neste E et al (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d’Etudes des Lymphomes de l’Adulte. Blood 16:2040–2045CrossRef

Pfreundschuh M, Schubert J, Ziepert M et al (2008) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20_B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 9:105–116CrossRefPubMed

Juweid ME, Wiseman GA, Vose JM et al (2005) Response assessment of aggressive non-Hodgkin’s lymphoma by integrated International Workshop Criteria and flouorine-18–fluorodeoxyglucose positron emission tomography. J Clin Oncol 23:4652–4661CrossRefPubMed

10.

Sehn LH, Savage KJ, Hoskins P (2011) Treatment of limited-stage DLBCL can be effectively tailored using a PET-based approach. Ann Oncol 22(suppl 4; abstr 28)

11.

Swerdlow AJ, Barber JA, Hudson GV et al (2000) Risk of second malignancy after Hodgkin’s disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 18:498–509PubMed

Title: Eine Strahlentherapie des initialen Bulks verbessert nach abgeschlossener Immunchemotherapie das Outcome älterer Patienten mit aggressivem B-Zell-Lymphom
Author: Prof. Dr. Stefan Kubicka
Publication date: 01-08-2014
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 8/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-014-0701-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Eine Strahlentherapie des initialen Bulks verbessert nach abgeschlossener Immunchemotherapie das Outcome älterer Patienten mit aggressivem B-Zell-Lymphom

Auszug

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 8/2014

Tangential vs. defined radiotherapy in early breast cancer treatment without axillary lymph node dissection

Erratum to: Incidental dose to coronary arteries is higher in prone than in supine whole breast irradiation

Erhöht die hypofraktionierte Strahlentherapie bei Mammakarzinom die kardiale Letalität innerhalb von 20 Jahren?

Erratum to: Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy: analysis of a randomized clinical trial

Personalbedarf der medizinischen Strahlenphysik in der Strahlentherapie im Vergleich zur aktuellen Richtlinie „Strahlenschutz in der Medizin“

Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy